Albright Hereditary Osteodystrophy
📧 Sign up to get email alerts when something new happens for Albright Hereditary Osteodystrophy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: Theophylline Treatment for Pseudohypoparathyroidism - Children 2-12 Years Old [Phase 2]
A Phase 2 clinical trial evaluating theophylline as treatment for pseudohypoparathyroidism in children aged 2-12; the study is currently act…
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: Theophylline for Treatment of Pseudohypoparathyroidism [Phase 2]
Phase 2 trial evaluating theophylline for treatment of pseudohypoparathyroidism; currently enrolling by invitation.
-
CLINICAL_TRIALS trial_result · 2026-02-20Clinical Trial Update: Theophylline Treatment for Pseudohypoparathyroidism [Phase 2]
Phase 2 clinical trial assessing theophylline for pseudohypoparathyroidism and Albright hereditary osteodystrophy; the study is active but n…
-
CLINICAL_TRIALS research · 2025-05-28Clinical Trial Update: Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments [NA]
Connecticut Children's Medical Center is conducting a recruiting study to characterize the natural history, growth, and cognitive/behavioral…
-
CLINICAL_TRIALS trial_result · 2018-06-08Clinical Trial Update: Early-onset Obesity and Cognitive Impairment in Children With Pseudohypoparathyroidism
A completed clinical trial evaluated early-onset obesity and cognitive impairment in children with pseudohypoparathyroidism and Albright her…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: Theophylline as a Treatment for Children With Pseudohypoparathyroidism Type 1a (Albright Hereditary Osteodystrophy) [Phase 2]
Phase 2 trial evaluating theophylline as a treatment for children with pseudohypoparathyroidism type 1a (Albright hereditary osteodystrophy)…